The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer

The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in... Human kallikrein-related peptidases are serine proteases, with diverse, yet poorly defined, roles in carcinogenesis. Recently, we have suggested that the dog may represent a suitable animal model for studying kallikrein (KLK) functions in cancer. The initial objective of the present study was to investigate KLK10 expression in cancerous and noncancerous canine mammary tissues. Our results revealed that the in silico predicted canine KLK10 mRNA sequence (GenBank accession No. XM_541467) is not accurate. Specifically, the predicted mRNA harbors a 183-bp segment, which constitutes part of (CANFA)KLK10 intron I, and a 756-bp sequence that corresponds to the nonpreviously characterized (CANFA)KLK9 coding region. In this report we experimentally determined the coding regions of canine KLK9 and KLK10, which were shown to exhibit high homology to their human counterparts and possess all KLK-defining features. For (CANFA)KLK9, other than the classical form of the gene, three more alternatively spliced variants bearing exon 3 skipping and/or intron I retention were identified. The classical form and variant 1 of KLK9, as well as KLK10, were found to be widely expressed among all tissues examined. Lower positivity rates were detected for KLK9 variants 2 and 3. None of these transcripts, however, showed any preferential or differential expression between tumor and normal tissues. Interestingly, (CANFA)KLK9 and (CANFA)KLK10 were concurrently expressed in almost all tissue samples; this suggests a possible participation of these serine proteases in a common proteolytic cascade. Overall, this is the first study that experimentally characterizes canine KLK9 and KLK10 and demonstrates their expression in normal and malignant tissues. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Mammalian Genome Springer Journals

The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer

Loading next page...
 
/lp/springer_journal/the-canine-kallikrein-related-peptidases-9-and-10-structural-kQGAzt6tc0
Publisher
Springer-Verlag
Copyright
Copyright © 2009 by Springer Science+Business Media, LLC
Subject
Life Sciences; Zoology ; Anatomy ; Cell Biology
ISSN
0938-8990
eISSN
1432-1777
D.O.I.
10.1007/s00335-009-9237-y
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial